Last $413.48 USD
Change Today +13.36 / 3.34%
Volume 722.5K
REGN On Other Exchanges
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Joseph J. LaRosa

Senior Vice President, General Counsel and Secretary, Regeneron Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 board members in 1 different organizations across 3 different industries.

See Board Relationships


Mr. Joseph J. Larosa, also known as Joe, has been Senior Vice President, Secretary and General Counsel at Regeneron Pharmaceuticals, Inc., since September 2011. Mr. LaRosa is responsible for overseeing all of the legal affairs, including general corporate legal matters, intellectual property and corporate compliance He served as General Counsel and Senior Vice President of Nycomed US, Inc. since November 10, 2010. Mr. Larosa was responsible for providing legal counsel ...

Read Full Background

Corporate Headquarters*

777 Old Saw Mill River Road
Tarrytown, New York 10591

United States

Phone: 914-347-7000
Fax: --

Board Members Memberships*



New York University
New York University School Of Law
New York University School Of Law

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
REGN:US $413.48 USD +13.36


Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
David E. I. Pyott Chairman and Chief Executive Officer
Allergan Inc.
Leonard Bell M.D.Co-Founder, Chairman of the Board and Chief Executive Officer
Alexion Pharmaceuticals, Inc.
Frederic Roch Doliveux DVMChief Executive Officer and Executive Director
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGENERON PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at